MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a multi-center, randomized, double blind, cross-over phase 2 clinical trial with autologous mesenchymal stem cells (MSC)

Creators

• Uccelli, A
• Laroni, A
• Brundin, L
• Clanet, M
• Fernandez, O
• Nabavi, SM
• Muraro, PA
• Oliveri, RS
• Radue, EW
• Sellner, JT
• Sorensen, PS
• Sormani, MP
• Wuerfel, JT
• Battaglia, MA
• Freedman, MS

Contributors